Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2015-05-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Status and Dose Response in Infants
NCT01042561
Vitamin D Serum Concentrations & Supplementation in Children With Cerebral Palsy
NCT01926808
Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants
NCT00381914
Effects of Vitamin D Dose and Genotype of the Binding Protein in Infants and Children
NCT01050387
Vitamin D Deficiency and Low Bone Mineral Content in Children
NCT00756899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
in our study, we will observe incidence of complication and severity of complication between patients who have different Vitamin D status.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
A. turbid appearance; B.leukocytosis (\> 100 cells/mm3); C.leukocytosis (10-100 cells/ mm3) AND either an elevated protein (\> 100 mg/dl) or decreased glucose (\< 40 mg/dl)
* Confirmed bacterial meningitis patients: A case that is laboratory-confirmed by growing (i.e. culturing) or identifying (i.e. by Gram stain or antigen detection methods) a bacterial pathogen (Hib, pneumococcus or meningococcus) in the cerebrospinal fluid or from the blood in a child with a clinical syndrome consistent with bacterial meningitis
Exclusion Criteria
* HIV patients
* Patients with corticosteroid treatment for long time
* Patients with disorders in adrenal gland and pituitary gland and hypothalamus
* Patients with tuberculosis
1 Month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gang Liu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gang Liu
director, chief physician, professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20150203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.